The US is the bigger Insulin Patch Pumps market: $374 Mn against $16 Mn in 2023, about 23 times as large.
India grows faster: 15% a year, against 10%. The gap still grows from $358 Mn to $904 Mn by 2033.
Clinical research: 6 active trials in the US, 0 in India.
| Measure |  US |  India |
|---|---|---|
| Market size, 2023 | $374 Mn | $16 Mn |
| Market size, 2033 projected | $970 Mn | $66 Mn |
| Growth a year (CAGR) | 10% | 15% |
| Money added, 2023–2033 | $596 Mn | $49 Mn |
| Share of the world market | 42% | 1.8% |
| Size rank of 24 countries | #1 | #12 |
| Market per person, 2023 | $1.09 | $0.01 |
| Active clinical trials | 6 | 0 |
| Diabetes (adults) % of adults (WHO) | 12.5 2022 | 22.6 2022 |
| Full report | US report | India report |
Year by year, 2023 to 2033
US India · values between 2023 and 2033 are projected from the 2023 size and the CAGR.
Quick answers
Which is bigger in Insulin Patch Pumps, US or India?
The US is the bigger Insulin Patch Pumps market: $374 Mn against $16 Mn in 2023, about 23 times as large.
Which grows faster in Insulin Patch Pumps, US or India?
India grows faster: 15% a year, against 10%. The gap still grows from $358 Mn to $904 Mn by 2033.
More Insulin Patch Pumps comparisons
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov (fetched 10 Nov 2026); found by search words, so counts are a guide. Health figures: WHO. Population: World Bank.